Business / Finance

RSS
BioMed declares $0.20 first quarter dividend

BioMed declares $0.20 first quarter dividend

Milestone Scientific commences trading on OTCQB

Milestone Scientific commences trading on OTCQB

Air Techniques' Spectra device leads caries detection aid category in sales

Air Techniques' Spectra device leads caries detection aid category in sales

Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Omthera to fund Epanova Phase 3 development with $33.9 million in Series B funding

Omthera to fund Epanova Phase 3 development with $33.9 million in Series B funding

Maricom opens third office in Lutherville

Maricom opens third office in Lutherville

HemaCare reports $7.0 million revenue for fourth quarter 2010

HemaCare reports $7.0 million revenue for fourth quarter 2010

Dehaier Medical enters distribution agreement with Shanghai Haopu for eVent's inspiration ventilators

Dehaier Medical enters distribution agreement with Shanghai Haopu for eVent's inspiration ventilators

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Fysicon to customize Merge solutions for BeNeLux market

Fysicon to customize Merge solutions for BeNeLux market

WaferGen Biosystems 2010 revenue exceeds guidance

WaferGen Biosystems 2010 revenue exceeds guidance

DaVita enhances company's governance policies and practices

DaVita enhances company's governance policies and practices

UnitedHealth Group ranked No. 1 on FORTUNE's 2011 'World's Most Admired Companies'

UnitedHealth Group ranked No. 1 on FORTUNE's 2011 'World's Most Admired Companies'

Ardea Biosciences fourth quarter net loss decreases to $0.6 million

Ardea Biosciences fourth quarter net loss decreases to $0.6 million

Verenium repurchases $28.4 million in outstanding convertible notes

Verenium repurchases $28.4 million in outstanding convertible notes

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

Bill Gates and Schrödinger co-founder invest in Nimbus to advance large B-cell lymphoma programs

Hooper Holmes fourth quarter consolidated revenues decline 4% to $43.4 million

Hooper Holmes fourth quarter consolidated revenues decline 4% to $43.4 million

Response Biomedical 2010 total revenues decrease to $7,610,827

Response Biomedical 2010 total revenues decrease to $7,610,827

CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009

CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009

BioSpecifics 2010 net loss decreases to $1.5 million

BioSpecifics 2010 net loss decreases to $1.5 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.